Filtros de búsqueda

Lista de obras de

A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.

artículo científico publicado en 2018

BET inhibition enhances the antileukemic activity of low-dose Venetoclax in acute myeloid leukemia

scientific article published on 04 November 2020

Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors

artículo científico publicado en 2016

Factors influencing preceptors' responses to medical errors: a factorial survey

scientific article published on 01 October 2005

HDAC3 is essential for DNA replication in hematopoietic progenitor cells.

artículo científico publicado en 2013

High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML.

artículo científico publicado en 2016

MTG16 is a tumor suppressor in colitis-associated carcinoma.

artículo científico publicado en 2017

MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model

artículo científico publicado en 2011

Mtg16/Eto2 Contributes to Murine T-Cell Development ⬇️

artículo científico publicado el 2 de mayo de 2011

Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence ⬇️

artículo científico publicado el 20 de enero de 2012

The characterization of the role of myeloid translocation gene 16 in hematopoietic progenitor and stem cell functions ⬇️

doctoral dissertation

Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes

artículo científico publicado en 2016

Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda